Increased Substrate Stiffness Elicits a Myofibroblastic Phenotype in Human Lamina Cribrosa Cells
Overview
Authors
Affiliations
Purpose: Alteration in the extracellular matrix (ECM) of the optic nerve head (ONH) causes lamina cribrosa (LC) fibrosis and affects the mechanical integrity of the ONH. Increased ECM tissue stiffness drives myofibroblast activation leading to tissue fibrosis throughout the body. Here using primary human LC cells, we investigate the effect of substrate stiffness on profibrotic changes, which might be a key molecular mechanism driving ECM remodeling of the LC in primary open-angle glaucoma (POAG) glaucoma.
Methods: Primary human LC cells from normal and age-matched POAG glaucoma donors were cultured on substrates with defined mechanical properties of 5 and 100 kPa to replicate the range of mechanical microenvironments that cells may experience in vivo. Cell morphology, spread area, actin stress fibers, vinculin-focal adhesion formation, and α-smooth muscle actin (α-SMA) signal were examined using immunofluorescence staining. The elastic modulus of cells was measured using atomic force microscopy (AFM).
Results: Significantly greater cell spread area along with increased actin filament development, and vinculin-focal adhesion formation (number and size) were found in both normal and glaucoma LC cells cultured on stiff substrates. These changes were positively associated with elevated cell stiffness measured by AFM. Changes in spreading and cytoskeleton organization of glaucoma LC cells were significantly more pronounced than those in normal cells. The transformation to a myofibroblast-like cell phenotype was identified in both LC cells exposed to stiffer substrates, as indicated by an increased α-SMA signal and its colocalization with the actin stress fibers.
Conclusions: These findings demonstrated that a stiffer cell microenvironment activates a myofibroblastic transformation in human LC cells, and therefore contributes to LC remodelling and fibrosis in glaucoma.
Fibrosis and Src Signalling in Glaucoma: From Molecular Pathways to Therapeutic Prospects.
Bourke L, OBrien C Int J Mol Sci. 2025; 26(3).
PMID: 39940776 PMC: 11817269. DOI: 10.3390/ijms26031009.
The Role of αvβ3 Integrin in Lamina Cribrosa Cell Mechanotransduction in Glaucoma.
Irnaten M, Gaynor E, OBrien C Cells. 2024; 13(17.
PMID: 39273058 PMC: 11394537. DOI: 10.3390/cells13171487.
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.
Millington-Ward S, Palfi A, Shortall C, Finnegan L, Bargroff E, Post I Int J Mol Sci. 2024; 25(16).
PMID: 39201561 PMC: 11354491. DOI: 10.3390/ijms25168876.
Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.
Mai Z, Lin Y, Lin P, Zhao X, Cui L Cell Death Dis. 2024; 15(5):307.
PMID: 38693104 PMC: 11063215. DOI: 10.1038/s41419-024-06697-4.
IOP and glaucoma damage: The essential role of optic nerve head and retinal mechanosensors.
Pitha I, Du L, Nguyen T, Quigley H Prog Retin Eye Res. 2023; 99:101232.
PMID: 38110030 PMC: 10960268. DOI: 10.1016/j.preteyeres.2023.101232.